The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
Open accessAbstract
BACKGROUND: The use of levothyroxine to treat subclinical hypothyroidism is controversial. We aimed to determine whether levothyroxine provided clinical benefits in older persons with this condition. METHODS: We conducted a double-blind, randomized, placebo-controlled, parallel-group trial involving 737 adults who were at least 65 years of age and who had persisting subclinical hypothyroidism (thyrotropin level, 4.60 to 19.99 mIU per liter; free thyroxine level within the reference range). A total of 368 patients were assigned to receive levothyroxine (at a starting dose of 50 μg daily, or 25 μg if the body weight was <50 kg or the patient had coronary heart disease), with dose adjustment according to the thyrotropin level; 369 patients were assigned to receive placebo with mock dose adjustment. The two primary outcomes were the change in the Hypothyroid Symptoms score and Tiredness score on a thyroid-related quality-of-life questionnaire at 1 year (range of each scale is 0 to 100, with higher scores indicating more symptoms or tiredness, respectively; minimum clinically important difference, 9 points). RESULTS: The mean age of the patients was 74.4 years, and 396 patients (53.7%) were women. The mean (±SD) thyrotropin level was 6.40±2.01 mIU per liter at baseline; at 1 year, this level had decreased to 5.48 mIU per liter in the placebo group, as compared with 3.63 mIU per liter in the levothyroxine group (P<0.001), at a median dose of 50 μg. We found no differences in the mean change at 1 year in the Hypothyroid Symptoms score (0.2±15.3 in the placebo group and 0.2±14.4 in the levothyroxine group; between-group difference, 0.0; 95% confidence interval [CI], -2.0 to 2.1) or the Tiredness score (3.2±17.7 and 3.8±18.4, respectively; between-group difference, 0.4; 95% CI, -2.1 to 2.9). No beneficial effects of levothyroxine were seen on secondary-outcome measures. There was no significant excess of serious adverse events prespecified as being of special interest. CONCLUSIONS: Levothyroxine provided no apparent benefits in older persons with subclinical hypothyroidism. (Funded by European Union FP7 and others; TRUST ClinicalTrials.gov number, NCT01660126 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“or to those with persistent subclinical hypothyroidism, where trials do not show a benefit from thyroid hormone replacement. 12,15,16,44 -46”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“No clear advantages of treating subclinical hypothyroidism in older individuals (>65 years) have been observed in terms of neurocognitive function and quality of life, 146-148”
From Hypothyroidism (2024) · cites this paper as [147]
The cited source says what the claim attributes to it.
In the citing paper
“large RCTs have shown no improvement in hypothyroid symptoms or quality of life (QoL) in older patients with subclinical hypothyroidism during treatment with levothyroxine. 15 -17”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“A large placebo-controlled trial among patients with subclinical hypothyroidism at least 65 years of age demonstrated no apparent benefits of LT4 treatment [51].”
From T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity (2021) · cites this paper as [51]
In the citing paper
“However, the meta-analysis included a significant proportion of elderly participants (mean age > 65 years) with mild TSH elevations which may reflect the aging process rather than intrinsic thyroid disease [18, 57].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [18]
In the citing paper
“Likewise, trials of levothyroxine therapy in elderly individuals with mild subclinical hypothyroidism have not shown clinical benefits [18, 57] and it is plausible that TSH elevations in these individuals did not represent intrinsic thyroid failure.”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [18]
In the citing paper
“Neither thyroid symptoms nor tiredness scores were changed significantly in the LT4 or placebo groups by 12 months”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“Reassuringly, there were no adverse effects of LT4.”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“Although the TSH levels in those on LT4 were reduced impressively, one-quarter of subjects were asymptomatic.”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“Confirmation of the elevated TSH is considered essential in establishing the diagnosis of subclinical hypothyroidism although this is not a guarantee of persistent thyroid failure”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“A total of 737 patients aged >65 years were recruited and the primary outcome parameter was QoL (Thyroid-Related Quality of Life Patient Reported Outcome [ThyPro] subscales for hypothyroid symptoms score and tiredness score).”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Katz, S. (1963) · JAMA · doi:10.1001/jama.1963.03060120024016 · Cited by 2,421
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
Self-citation2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
Razvi, S., Ingoe, L., Keeka, G., Oates, C., McMillan, C., & Weaver, J. U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1869 · Cited by 389
Grip Strength in Healthy Caucasian Adults: Reference Values
Günther, C., Bürger, A., Rickert, M., Crispin, A., & Schulz, C. U. (2008) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2008.01.008 · Cited by 366
Monzani, F., Di Bello, V., Caraccio, N., Bertini, A., Giorgi, D., Giusti, C., & Ferrannini, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7291 · Cited by 308
Research works printed but not linked: 4
- Baumgartner C, 2015, Swiss Med Wkly, 145, w14156
- Villar HC, 2007, Cochrane Database Syst Rev, 3, CD003419
- Mahoney FI, 1965, Md State Med J, 14, 61
- McClure NS, Value Health
Cited by
Sorted by citations
Items 101–200 of 499
Mammen, J. S., McGready, J., Ladenson, P. W., & Simonsick, E. M. (2017) · Thyroid® · doi:10.1089/thy.2017.0211 · Cited by 34
Grossman, A., Feldhamer, I., & Meyerovitch, J. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.11.010 · Cited by 34
Hypothyroidism: Cardiovascular Endpoints of Thyroid Hormone Replacement
Stamatouli, A. M., Bedoya, P., & Yavuz, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00888 · Cited by 34
Gonzalez Rodriguez, E., Stuber, M., Del Giovane, C., Feller, M., Collet, T.-H., Löwe, A. L., Blum, M. R., van Vliet, N. A., van Heemst, D., Kearney, P. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz058 · Cited by 33
Self-citationIngoe, L. E., Phipps, N., Armstrong, G., Rajagopal, A., Kamali, F., & Razvi, S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13440 · Cited by 35
Thyroid Function in Aging: A Discerning Approach
Duntas, L. H. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1991 · Cited by 33
Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021)
Liu, Y., Shan, Z., & Endocrine Metabolic Diseases Group of the Chinese Geriatrics Society (2021) · Aging Medicine · doi:10.1002/agm2.12165 · Cited by 33
Determining minimal important change for the thyroid related quality of life questionnaire ThyPRO
Nordqvist, S. F., Boesen, V. B., Rasmussen, Å. K., Feldt-Rasmussen, U., Hegedüs, L., Bonnema, S. J., Cramon, P. K., Watt, T., Groenvold, M., & Bjorner, J. B. (2021) · Endocrine Connections · doi:10.1530/ec-21-0026 · Cited by 31
Self-citationApproach to the Patient With Immune Checkpoint Inhibitor–Associated Endocrine Dysfunction
Wright, J. J., & Johnson, D. B. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac689 · Cited by 31
van der Spoel, E., van Vliet, N. A., Poortvliet, R. K. E., Puy, R. S. D., den Elzen, W. P. J., Quinn, T. J., Stott, D. J., Sattar, N. A., Kearney, P. M., Blum, M. R., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad623 · Cited by 33
Self-citationThyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension
Jankauskas, S. S., Morelli, M. B., Gambardella, J., Lombardi, A., & Santulli, G. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14152 · Cited by 31
Aging Is Associated with Low Thyroid State and Organ-Specific Sensitivity to Thyroxine
Rakov, H., Angelis, M. D., Renko, K., Hönes, G. S., Zwanziger, D., Moeller, L. C., Schramm, K., & Führer, D. (2019) · Thyroid · doi:10.1089/thy.2018.0377 · Cited by 30
Tsai, T., Tu, Y., Munir, K. M., Lin, S., Chang, R. H., Kao, S., Loh, C., Peng, C. C., & Huang, H. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz186 · Cited by 31
Thyroid Function Reference Intervals by Age, Sex, and Race
Li, Q., Tang, Y., Yu, X., Qin, G., Tian, L., Cheng, L., Lü, Y., Zhao, Z., Liu, L., Zhang, K., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-01559 · Cited by 29
van Vliet, N. A., Bos, M. M., Thesing, C. S., Chaker, L., Pietzner, M., Houtman, E., Neville, M. J., Li‐Gao, R., Trompet, S., Mustafa, R., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02130-1 · Cited by 31
Self-citationDu Puy, R. S., Poortvliet, R. K. E., Mooijaart, S. P., den Elzen, W. P. J., Jagger, C., Pearce, S. H. S., Arai, Y., Hirose, N., Teh, R., Menzies, O., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0567 · Cited by 27
Self-citationSanyal, D., Ray, S., & Malhi, H. S. (2022) · Endocrine Regulations · doi:10.2478/enr-2022-0033 · Cited by 27
Borson‐Chazot, F., Terra, J., Goichot, B., & Caron, P. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071386 · Cited by 27
Does Subclinical Hypothyroidism Add Any Symptoms? Evidence from a Danish Population-Based Study
Carlé, A., Karmisholt, J. S., Knudsen, N., Perrild, H., Thuesen, B. H., Ovesen, L., Rasmussen, L. B., & Pedersen, I. B. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.03.009 · Cited by 25
Age-Related Resistance to Thyroid Hormone Action
Mooradian, A. D. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00711-7 · Cited by 26
You, A. S., Kalantar‐Zadeh, K., Brent, G. A., Narasaki, Y., Daza, A. C., Sim, J. J., Kovesdy, C. P., Nguyen, D. V., & Rhee, C. M. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.08.028 · Cited by 25
Song, M., Sun, W., Liu, Q., Wang, Z., & Zhang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1306232 · Cited by 24
Zhang, K., Tang, Y., Zhang, Y., Ojamaa, K., Li, Y., Saini, A. S., Carrillo-Sepúlveda, M. A., Rajagopalan, V., & Gerdes, A. M. (2018) · Thyroid · doi:10.1089/thy.2017.0544 · Cited by 24
A comprehensive nutritional survey of hospitalized patients: Results from nutritionDay 2016 in China
Sun, H., Zhang, L., Zhang, P., Yu, J., Kang, W., Guo, S., Chen, W., Li, X., Wang, S., Chen, L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194312 · Cited by 24
Wang, X., Zhao, X., & Huang, X. (2019) · Endocrine Research · doi:10.1080/07435800.2019.1645164 · Cited by 24
Thyroid hormone therapy for subclinical hypothyroidism
Magri, F., Chiovato, L., Croce, L., & Rotondi, M. (2019) · Endocrine · doi:10.1007/s12020-019-02039-z · Cited by 24
Cardioprotection and Thyroid Hormones in the Clinical Setting of Heart Failure
Mastorci, F., Sabatino, L., Vassalle, C., & Pingitore, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00927 · Cited by 24
Thyroid Hormone Use in the United States, 1997–2016
Johansen, M. E., Marcinek, J. P., & Doo Young Yun, J. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.02.190159 · Cited by 23
Evaluating health outcomes in the treatment of hypothyroidism
Ettleson, M. D., & Papaleontiou, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1026262 · Cited by 26
Decision Making in Subclinical Thyroid Disease
Evron, J. M., & Papaleontiou, M. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.05.014 · Cited by 25
Thyroid Function and Cognitive Decline: A Narrative Review
Sinha, S. H., Zietlow, K. E., & Papaleontiou, M. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.07.013 · Cited by 23
Recker, S., Voigtlaender, R., Viehmann, A., Dunschen, K., Kerp, H., Frank‐Raue, K., Leidig‐Bruckner, G., Graf, D., Lederbogen, S., Dietrich, J. W., et al. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0897-8785 · Cited by 22
Self-citationHypothyroidism and hypertension: fact or myth? – Authors' reply
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33321-4 · Cited by 22
T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
Wiersinga, W. M. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.501 · Cited by 21
He, W., Li, S., Wang, B., Mu, K., Shao, X., Yao, Q., Li, L., Li, Q., & Zhang, J.-A. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000001826 · Cited by 21
Kim, J., Prasitlumkum, N., Randhawa, S., & Banerjee, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153318 · Cited by 22
Brigante, G., Santi, D., Boselli, G., Margiotta, G., Corleto, R., Monzani, M. L., Craparo, A., Locaso, M., Sperduti, S., Roy, N., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad172 · Cited by 22
Combination Thyroid Hormone Replacement; Knowns and Unknowns
Taylor, P. N., Eligar, V. S., Muller, I., Scholz, A., Dayan, C. M., & Okosieme, O. E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00706 · Cited by 22
Tan, N. C., Chew, R. Q., Subramanian, R. C., Sankari, U., Koh, Y. L. E., & Cho, L. W. (2018) · Family Practice · doi:10.1093/fampra/cmy064 · Cited by 21
Wang, X., Wang, H., Li, Q., Wang, P., Xing, Y., Zhang, F., Li, J., & Shan, Z. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac417 · Cited by 20
Calcaterra, V., Magenes, V. C., Siccardo, F., Hruby, C., Basso, M., Conte, V., Maggioni, G., Fabiano, V., Russo, S., Veggiotti, P., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1205331 · Cited by 20
Mammen, J. S. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.008 · Cited by 20
Ku, E. J., Yoo, W. S., & Chung, H. K. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1778 · Cited by 21
Zhao, C., Wang, Y., Xiao, L., & Li, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.913749 · Cited by 19
“14; I(2) = 0%) (13, 14, 19) (Figure 6B), all-cause death (p = 0.”
InfluentialFunctional and Symptomatic Individuality in the Response to Levothyroxine Treatment
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00664 · Cited by 22
Wang, W., Zhang, X., Gao, J. L., Meng, X., Wang, J., Zhang, K., Chen, J., Qi, J., Shao, C., & Tang, Y. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101473 · Cited by 23
The Two Faces of Janus: Why Thyrotropin as a Cardiovascular Risk Factor May Be an Ambiguous Target
Dietrich, J. W., Hoermann, R., Midgley, J. E. M., Bergen, F., & Müller, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.542710 · Cited by 19
Kalaria, T., Sanders, A., Fenn, J. S., Ashby, H. L., Mohammed, P., Buch, H., Ford, C., & Gama, R. M. (2021) · Clinical Endocrinology · doi:10.1111/cen.14423 · Cited by 19
Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)
Troshina, E. A., Panfilova, E. A., Mikhina, M. S., Kim, I. V., Семеновна, С. Е., Glibka, A. A., Shifman, B. M., Александровна, Л. А., Шеремета, М. С., Degtyarev, M. V., et al. (2021) · Problems of Endocrinology · doi:10.14341/probl12747 · Cited by 19
Netzer, S., Chocano-Bedoya, P. O., Feller, M., Janett-Pellegri, C., Wildisen, L., Büchi, A. E., Moutzouri, E., Rodríguez, E. G., Collet, T., Poortvliet, R. K. E., et al. (2023) · Age and Ageing · doi:10.1093/ageing/afac326 · Cited by 19
Self-citationDomingo, F. R., Avey, M. T., & Doull, M. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1181-7 · Cited by 19
Sawka, A. M., Cappola, A. R., Peeters, R. P., Kopp, P. A., Bianco, A. C., & Jonklaas, J. (2019) · Thyroid · doi:10.1089/thy.2019.0494 · Cited by 19
Baretella, O., Blum, M. R., Abolhassani, N., Alwan, H., Wildisen, L., Giovane, C. D., Tal, K., Moutzouri, E., Åsvold, B. O., Cappola, A. R., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae860 · Cited by 20
Self-citationGoichot, B., Raverot, V., Klein, M., Racaru, L. V., Payrat, J. A.-D., Lairez, O., Leroy, R., Cailleux, A., Wolff, P., Groussin, L., et al. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.04.010 · Cited by 18
Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design
Madan, R., & Celi, F. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00371 · Cited by 18
Sociodemographic Disparities in the Treatment of Hypothyroidism: NHANES 2007–2012
Ettleson, M. D., Bianco, A. C., Zhu, M., & Laiteerapong, N. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab041 · Cited by 18
Prevalence and factors associated with chronic use of levothyroxine: A cohort study
Janett-Pellegri, C., Wildisen, L., Feller, M., Del Giovane, C., Moutzouri, E., Grolimund, O., Walter, P., Waeber, G., Marques-Vidal, P., Vollenweider, P., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0261160 · Cited by 17
Self-citationHolley, M., Razvi, S., Farooq, M. S., Dew, R., Maxwell, I., & Wilkes, S. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02548-7 · Cited by 17
Wang, X., Wang, H., Yan, L., Yang, L., Xue, Y., Yang, J., Yao, Y., Tang, X., Tong, N., Wang, G., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1101 · Cited by 17
Implementation of thyroid-related patient-reported outcomes in routine clinical practice
Cramon, P. K., Bjørner, J. B., Grøenvold, M., Boesen, V. B., Bonnema, S. J., Hegedűs, L. D., Feldt‐Rasmussen, U., Rasmussen, Å. K., & Watt, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1000682 · Cited by 17
Self-citationKrieg, V. J., Hobohm, L., Liebetrau, C., Guth, S., Koelmel, S., Troidl, C., Mayer, E., Konstantinides, S., Wiedenroth, C. B., & Lankeit, M. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.10.025 · Cited by 17
Stuber, M. J., Moutzouri, E., Feller, M., Giovane, C. D., Bauer, D. C., Blum, M. R., Collet, T., Gussekloo, J., Mooijaart, S. P., Carthy, V. J. C. M., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa123 · Cited by 17
Self-citationIzkhakov, E., Zahler, D., Rozenfeld, K.-L., Ravid, D., Banai, S., Topilsky, Y., Stern, N., Greenman, Y., & Shacham, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123829 · Cited by 17
Fitzgerald, S. P., Bean, N. G., Hennessey, J. V., & Falhammar, H. (2021) · Endocrine · doi:10.1007/s12020-021-02851-6 · Cited by 16
Fitzgerald, S. P., & Falhammar, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.920854 · Cited by 17
Kerp, H., Hönes, G. S., Tolstik, E., Hönes-Wendland, J., Gassen, J., Moeller, L. C., Lorenz, K., & Führer, D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.683522 · Cited by 15
Fu, J., Wang, Y., Liu, Y., Song, Q., Cao, J., & Wang, P. (2022) · Journal of Medical Biochemistry · doi:10.5937/jomb0-39570 · Cited by 16
Cardiovascular outcomes in subclinical thyroid disease: an update
Ettleson, M. D. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000818 · Cited by 15
Capalbo, D., Alfano, S., Polizzi, M., Mase, R. D., Improda, N., Esposito, A. A., Bravaccio, C., & Salerno, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa046 · Cited by 15
A practical contemporary approach to decision-making on subclinical hypothyroidism
Sgarbi, J. A., & Ward, L. S. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000317 · Cited by 15
Impact of subclinical hypothyroidism on health‐related quality of life: a narrative review
Danicic, J. M., Inder, W. J., & Kotowicz, M. A. (2021) · Internal Medicine Journal · doi:10.1111/imj.15431 · Cited by 15
A Clinical Debate: Subclinical Hypothyroidism
Jasim, S., Abdi, H., Gharib, H., & Biondi, B. (2021) · Intern J Endocrinol Metab · doi:10.5812/ijem.115948 · Cited by 15
Büchi, A. E., Feller, M., Netzer, S., Blum, M. R., Gonzalez Rodriguez, E., Collet, T.-H., Del Giovane, C., van Heemst, D., Quinn, T., Kearney, P. M., et al. (2022) · Bone · doi:10.1016/j.bone.2022.116404 · Cited by 14
Self-citationWang, P., Zhang, W., & Liu, H. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1527271 · Cited by 16
Thyroid dysfunction and cardiovascular disease
Alwan, H., Hysaj, O., Gencer, B., Duntas, L. H., & Rodondi, N. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag248 · Cited by 15
Self-citationAbbey, E. J., McGready, J., Sokoll, L. J., Simonsick, E. M., & Mammen, J. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.858332 · Cited by 14
Improving the clinical impact of randomised trials in thyroidology
Korevaar, T. I. M., Chaker, L., & Peeters, R. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30316-9 · Cited by 14
Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches
Rizzo, C., Gioia, M. I., Parisi, G., Triggiani, V., & Iacoviello, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_132 · Cited by 14
Interpreting elevated TSH in older adults
Mammen, J. S. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.04.001 · Cited by 14
Diagnosis and treatment of hypothyroidism in old people
Borzì, A. M., Biondi, A., Basile, F., & Vacante, M. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-01579-8 · Cited by 14
Puy, R. S. D., Postmus, I., Stott, D. J., Blum, M. R., Poortvliet, R. K. E., den Elzen, W. P. J., Peeters, R. P., Munster, B. C. V., Wolffenbuttel, B. H. R., Westendorp, R. G. J., et al. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0285-8 · Cited by 14
Self-citationKarmisholt, J., & Andersen, S. (2019) · European Thyroid Journal · doi:10.1159/000496827 · Cited by 14
The importance of high-quality mendelian randomisation studies for clinical thyroidology
Medici, M., Peeters, R. P., Teumer, A., & Taylor, P. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30145-7 · Cited by 14
Aleksić, Ž., Aleksić, A., & Đorđević, B. (2022) · Timocki medicinski glasnik · doi:10.5937/tmg2201011a · Cited by 14
Hypothyroidism and hypertension: fact or myth?
Hofstetter, L., & Messerli, F. H. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33320-2 · Cited by 14
Urgent need for further research in subclinical hypothyroidism
Taylor, P., & Bianco, A. C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0239-x · Cited by 14
Management of thyroid dysfunction and thyroid nodules in the ageing patient
Martínez‐Montoro, J. I., Doulatram‐Gamgaram, V. K., Olveira, G., Valdés, S., & Fernández‐García, J. C. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.005 · Cited by 13
Boronat, M., González-Lleó, A. M., Rodríguez-Pérez, C., Feldt‐Rasmussen, U., López-Plasencia, Y., Rasmussen, Å. K., Alberiche-Ruano, M. P., Hegedűs, L. D., Alvarado-Martel, D., Bonnema, S. J., et al. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.06.010 · Cited by 13
Self-citationBauer, B. S., Azcoaga-Lorenzo, A., Agrawal, U., Fagbamigbe, A. F., & McCowan, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268070 · Cited by 12
Efthymiadis, A., Henry, M., Spinos, D., Bourlaki, M., Tsikopoulos, A., Bourazana, A., Bastounis, A., & Tsikopoulos, K. (2023) · Clinical Endocrinology · doi:10.1111/cen.14998 · Cited by 12
Kuś, A., Sterenborg, R. B. T. M., Haug, E. B., Galesloot, T. E., Visser, W. E., Smit, J. W. A., Bednarczuk, T., Peeters, R. P., Åsvold, B. O., Teumer, A., et al. (2024) · Thyroid · doi:10.1089/thy.2024.0045 · Cited by 13
Self-citationSubclinical Hypothyroidism with TSH>7 mIU/l and≤10 mIU/l and Coronary Artery Disease
Rosário, P. W., & Calsolari, M. R. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1083-6509 · Cited by 12
Towards De-Implementation of low-value thyroid care in older adults
Perkins, J. M., & Papaleontiou, M. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000758 · Cited by 12
Thyroid dysfunction in peri- and postmenopausal women—cumulative risks
Frank‐Raue, K., & Raue, F. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0069 · Cited by 13
Abbey, E. J., McGready, J., Ferrucci, L., Simonsick, E. M., & Mammen, J. S. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17015 · Cited by 12
Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy
Hegedüs, L., & Brix, T. H. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1707415 · Cited by 12
Considerations in the Diagnosis and Management of Thyroid Dysfunction in Older Adults
Jasim, S., & Papaleontiou, M. (2025) · Thyroid · doi:10.1089/thy.2025.0128 · Cited by 13
Inference after covariate-adaptive randomisation: aspects of methodology and theory
Shao, J. (2021) · Statistical Theory and Related Fields · doi:10.1080/24754269.2021.1871873 · Cited by 11
Pandrc, M. S., Ristić, A., Kostovski, V., Milin-Lazovic, J. S., & Ćirić, J. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14577 · Cited by 11
Triggiani, V., Cittadini, A., & Lisco, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1013641 · Cited by 11
Metadata
- Authors
- Stott, D. J., Rodondi, N., Kearney, P. M., Ford, I., Westendorp, R. G. J., Mooijaart, S. P., Sattar, N., Aubert, C. E., Aujesky, D., Bauer, D. C., Baumgartner, C., Blum, M. R., Browne, J. P., Byrne, S., Collet, T.-H., Dekkers, O. M., den Elzen, W. P. J., Du Puy, R. S., Ellis, G., Feller, M., Floriani, C., Hendry, K., Hurley, C., Jukema, J. W., Kean, S., Kelly, M., Krebs, D., Langhorne, P., McCarthy, G., McCarthy, V., McConnachie, A., McDade, M., Messow, M., O’Flynn, A., O’Riordan, D., Poortvliet, R. K. E., Quinn, T. J., Russell, A., Sinnott, C., Smit, J. W. A., Van Dorland, H. A., Walsh, K. A., Walsh, E. K., Watt, T., Wilson, R., & Gussekloo, J.
- Affiliations
- University of Bern (CH)
- ORCID
- Stott, David J.
- Rodondi, Nicolas
- Kearney, Patricia M.
- Ford, Ian
- Westendorp, Rudi G.J.
- Mooijaart, Simon P.
- Sattar, Naveed
- Aubert, Carole E.
- Aujesky, Drahomir
- Bauer, Douglas C.
- Baumgartner, Christine
- Blum, Manuel R.
- Browne, John P.
- Byrne, Stephen
- Collet, Tinh-Hai
- Dekkers, Olaf M.
- Ellis, Graham
- Feller, Martin
- Hurley, Caroline
- Jukema, J. Wouter
- Kean, Sharon
- Langhorne, Peter
- McConnachie, Alex
- Poortvliet, Rosalinde K.E.
- Quinn, Terence J
- Russell, Audrey
- Sinnott, Carol
- Walsh, Kieran A.
- Walsh, Elaine K.
- Watt, Torquil
- Gussekloo, Jacobijn
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-06-29
- Volume
- 376
- Issue
- 26
- Pages
- 2534-2544
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2604882706
- Cited by
- 490
- References
- 25
- Citations by year
- 2026: 42 · 2025: 28 · 2024: 43 · 2023: 47 · 2022: 54 · 2021: 61 · 2020: 62 · 2019: 61 · 2018: 64 · 2017: 27
- FWCI
- 46.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- Arrow@dit (Dublin Institute of Technology) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- IRIS (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- Cork Open Research Archive (University College Cork, Ireland) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- National Science Foundation
- Velux Stiftung
- University of Bern
- Health Research Board (SPHeRE/2013/1)
- Inselspital, Universitätsspital Bern
- European Commission (278148, FP7‐HEALTH‐2011)
- University of Glasgow
- University College Cork
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (165409, 320 030-150 025, 150025, 278148, 167826, 320030)
- Universiteit Leiden
- Radboud Universiteit
- Gentofte Hospital
- Schweizerische Herzstiftung (278148)
- Leids Universitair Medisch Centrum
- Rigshospitalet
- Radboud Universitair Medisch Centrum
- University of California, San Francisco
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24AR051895)
- FP7 Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- subclinical hypothyroidism, levothyroxine, thyroid hormone replacement, older adults, quality of life, fatigue, thyroid-stimulating hormone, dose adjustment, coronary artery disease, body weight, cost-effectiveness, patient-reported outcomes, health-related quality of life
- MeSH terms
- Aged, Aged, 80 and over, Double-Blind Method, Fatigue, Female, Humans, Hypothyroidism, Male, Quality of Life, Thyrotropin, Thyroxine, Treatment Failure, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
